Cannabis can trigger seizures under specific circumstances, even though one of its components is an FDA-approved seizure medication. The apparent contradiction comes down to which compounds are involved, how much is consumed, and who is consuming it. A scoping review of acute cannabis exposures found higher seizure rates than would be expected in the general population, and THC in particular may increase neuronal excitability in ways that lower the seizure threshold. The full picture, though, involves withdrawal effects, drug interactions, synthetic products, and accidental pediatric ingestions, each carrying its own level of risk.
THC and CBD Pull in Opposite Directions
The cannabis plant contains over a hundred cannabinoids, but the two that matter most for seizure risk are THC and CBD. They have strikingly different effects on the brain’s electrical stability. CBD has demonstrated clear antiseizure properties in clinical trials and earned FDA approval for treating severe epilepsy syndromes. THC, on the other hand, is the primary psychoactive compound and may alter neuronal excitability in ways that can worsen seizure activity.1ScienceDirect / Elsevier. The role of cannabis in epilepsy illustrated by two case reports
Animal research helps explain the mechanism. When mice were given a drug that activates the same receptor THC targets (the CB1 receptor), their seizure threshold went up, meaning they were harder to provoke into a seizure. But when they were given a drug that blocks that receptor, the seizure threshold dropped, making seizures easier to trigger.2Neuropharmacology. The interaction of cannabinoids and opioids on pentylenetetrazole-induced seizure threshold in mice This might sound like THC should be protective, since it activates CB1 receptors. But the receptor system is more complicated in humans, where dose, tolerance, and the mix of other cannabinoids all shift the outcome. At recreational doses in a whole-plant product, THC’s net effect on seizure risk is not reliably protective and may tip the other way.
CBD works through a different set of targets entirely. Rather than binding strongly to CB1 receptors, it interacts with ion channels and other receptors that help quiet overexcited neurons.3PubMed. The proposed mechanisms of action of CBD in epilepsy This distinction matters because the ratio of THC to CBD varies enormously across cannabis products. A high-THC concentrate with almost no CBD is a very different substance, pharmacologically speaking, than a CBD-dominant tincture.
What Emergency Data Show About Acute Use
The clearest signal that cannabis can provoke seizures comes from emergency department records. A scoping review looking at acute cannabis exposures found that ten out of eleven studies reported seizure rates higher than you would expect based on how common epilepsy is in the general population. The remaining studies showed increased seizure frequency or seizure-related hospitalizations among recreational users and people with cannabis use disorder.4PubMed Central. The Potential Proconvulsant Effects of Cannabis: a Scoping Review
That does not prove cannabis directly caused every one of those seizures. Emergency department populations are messy: people who show up may have used other substances, may have undiagnosed epilepsy, or may have been sleep-deprived and dehydrated. But the pattern is consistent enough across multiple studies that researchers take the proconvulsant possibility seriously, especially at high doses.
Children who accidentally ingest cannabis edibles present a more controlled picture, since they typically have no other drug exposures. In a review of pediatric cases, seizures occurred in roughly 1.8% of presentations, alongside coma at a similar rate and respiratory depression at 1.7%.5BC Medical Journal. Unintentional cannabis exposure in children and youth: A review of clinical presentations and management Those numbers are low in percentage terms, but they confirm that cannabis alone, without any other substance in the mix, can produce seizures in a developing brain.
Cannabis Withdrawal and Rebound Excitability
One of the less intuitive ways cannabis relates to seizures has nothing to do with being high. It happens when regular users stop. Animal studies have shown that after sustained THC exposure, withdrawal produces a state of brain hyperexcitability, essentially the opposite of the calming effect THC had while it was on board. In mice, this rebound excitability lowered the threshold for electrically induced seizures, leading researchers to warn that stopping cannabis abruptly could jeopardize seizure control in people with epilepsy.6PubMed Central. Subacute cannabinoid treatment: anticonvulsant activity and withdrawal excitability in mice
This is particularly relevant for people who use cannabis daily and then suddenly lose access, whether because of a legal issue, a change in supply, or a deliberate attempt to quit. The withdrawal period, typically peaking a few days after the last use, is when the brain is most vulnerable. If you have epilepsy and use cannabis regularly, stopping cold turkey without medical guidance carries real risk. Tapering is the safer approach, and any changes should involve your neurologist.
Synthetic Cannabinoids Are a Different Beast
Products sold under names like Spice or K2 are not cannabis. They are synthetic chemicals sprayed onto plant material, designed to activate the same CB1 receptors that THC does but often binding far more powerfully. This stronger binding translates into higher toxicity, longer-lasting effects, and a side-effect profile that looks nothing like what you see with marijuana. Seizures, psychosis, and dangerous heart rhythms are among the toxic effects, and these are not typically seen with natural cannabis.7PubMed Central. The secret “spice”: an undetectable toxic cause of seizure
A systematic review of synthetic cannabinoid toxicity found that compared with other drugs, these compounds have a high potential to trigger convulsions, decreased consciousness, and cardiovascular instability. People with epilepsy or schizophrenia face especially elevated risk because these synthetics can precipitate both neurological and psychiatric crises.8PubMed Central. Toxicity of Synthetic Cannabinoids in K2/Spice: A Systematic Review The challenge is that many users do not realize what they are consuming. Synthetic cannabinoids are often marketed as legal alternatives to marijuana and may not be disclosed on the packaging. If someone reports a seizure after using what they thought was weed, the actual substance involved could be something far more dangerous.
People with Epilepsy Who Use Cannabis Recreationally
There is an important gap between cannabis as a prescribed epilepsy treatment and cannabis as something a person with epilepsy buys from a dispensary or a friend. A study presented at the American Epilepsy Society found that cannabis consumers with epilepsy had significantly higher counts of generalized tonic-clonic seizures compared with non-consumers. About 48% of cannabis users in the study experienced these major seizures, versus roughly 18% of non-users.9www.aesnet.org. Impact of Cannabis Consumption on Seizure Frequency and Lifestyle Factors in Epileptic Patients
A caveat here: cannabis consumers in that study were also significantly more likely to smoke cigarettes and drink alcohol, both of which can independently affect seizure control. It is hard to isolate the effect of cannabis from the broader lifestyle pattern. Still, the finding runs counter to the popular belief that cannabis is categorically helpful for epilepsy. In uncontrolled, recreational settings, without pharmaceutical-grade CBD at measured doses, the net effect on seizure frequency may be harmful rather than protective.
Drug Interactions with Seizure Medications
If you take anti-seizure medication and also use cannabis, drug interactions are a real concern. CBD in particular is a potent inhibitor of certain liver enzymes that metabolize common epilepsy drugs. The best-documented interaction involves clobazam: CBD blocks the enzyme that breaks down clobazam’s active metabolite, causing its levels to build up in the blood. This can lead to excessive sedation and other side effects.10PubMed Central. Final analysis of potential drug–drug interactions between highly purified cannabidiol and anti‐seizure medications in an open‐label expanded access program
Clobazam is not the only concern. A narrative review identified potential interactions between CBD and at least fifteen other anti-seizure medications, including topiramate, zonisamide, phenobarbital, and several others.11Seizure. Interaction of cannabidiol with other antiseizure medications: A narrative review Some of these interactions raise drug levels, increasing side effects; others could lower drug levels, reducing seizure protection. The takeaway is straightforward: if you are on anti-seizure medication, adding cannabis products without telling your doctor is gambling with your drug levels. Even over-the-counter CBD supplements can shift the equation.
Fainting Spells That Look Like Seizures
Not every episode of shaking and loss of consciousness after cannabis use is actually a seizure. Cannabis can cause a drop in blood pressure, especially when combined with heat, standing up quickly, or physical exertion. That blood-pressure drop can produce syncope, a fainting spell, which may include brief shaking or jerking that looks alarming but is not a true seizure.
A case report described a 34-year-old man who lost consciousness after cannabis use during physical activity in a hot shower. His spouse found him on the floor, shaking, but he regained consciousness within minutes without the confusion, tongue biting, or loss of bladder control that typically follow a generalized seizure.12PubMed Central. Loss of Consciousness in a 34 Yo Male Related to Marijuana Events like this are likely more common than true cannabis-triggered seizures, but they can be difficult to distinguish in the moment. If you or someone around you experiences a collapse after using cannabis, the presence or absence of a prolonged postictal state (the groggy, confused period after a real seizure) is one of the most reliable ways to tell the difference.
The Flip Side: CBD as a Proven Anti-Seizure Treatment
The irony of this topic is that one cannabis-derived compound is among the most important epilepsy drugs developed in recent years. Pharmaceutical-grade CBD (sold as Epidiolex) was approved after rigorous clinical trials in patients with Lennox-Gastaut syndrome and Dravet syndrome, two severe childhood epilepsy types that resist most other treatments.
In a pivotal trial for Lennox-Gastaut syndrome, the higher CBD dose group saw a roughly 42% median reduction in drop seizures, compared with about 17% in the placebo group.13PubMed. Effect of Cannabidiol on Drop Seizures in the Lennox-Gastaut Syndrome Across the broader trial program covering both syndromes, CBD reduced key seizure types by 17% to 23% more than placebo when added to existing medications.14PubMed. Cannabidiol: A New Hope for Patients With Dravet or Lennox-Gastaut Syndromes Long-term follow-up data are encouraging too: over three years of open-label treatment, drop seizures decreased by roughly 48% to 71% from baseline, and the vast majority of patients or caregivers reported improvement in overall condition.15PubMed. Long-term safety and efficacy of add-on cannabidiol in patients with Lennox-Gastaut syndrome: Results of a long-term open-label extension trial
These results are impressive but come with a critical detail: they were achieved with a purified, precisely dosed pharmaceutical product administered under medical supervision. The CBD gummies at your local gas station are not the same thing. Unregulated CBD products vary wildly in actual CBD content, may contain undisclosed THC, and sometimes contain contaminants. One analysis of artisanal cannabis products used for childhood epilepsy in Australia found that about 29% of samples contained residual solvents above accepted limits, and one sample had nearly five times the acceptable level of a pesticide.16Epilepsy & Behavior. Determination of contaminants in artisanal cannabis products used for childhood epilepsy in the Australian community: A sub-analysis of the ‘PELICAN’ study Quality control matters enormously when the goal is seizure management.
The Adolescent Brain and Cannabis
Young people deserve a separate mention because the adolescent brain processes cannabis differently than the adult brain. The endocannabinoid system plays an active role in brain development during the teenage years, and disrupting it with external cannabinoids during this window may lead to structural and functional brain changes that persist into adulthood.17PubMed Central. Is the Adolescent Brain at Greater Vulnerability to the Effects of Cannabis? A Narrative Review of the Evidence While the existing research focuses more on cognitive and psychiatric outcomes than on seizure risk specifically, the general principle applies: a brain still under construction is more vulnerable to disruption. The pediatric emergency department data showing seizures in accidental cannabis ingestions underscore that younger brains are not simply smaller versions of adult ones when it comes to handling THC.
Other Cannabinoids Under Investigation
Beyond CBD, researchers are looking at several “minor” cannabinoids that appear in much smaller quantities in the plant. Cannabidivarin (CBDV), a close chemical relative of CBD, has shown efficacy in animal models of epilepsy across a range of doses. Cannabichromene (CBC) and tetrahydrocannabivarin (THCV) have also shown promise in preclinical seizure models.18PubMed Central. A systematic review of minor phytocannabinoids with promising neuroprotective potential Cannabigerol (CBG) has been studied in models of Huntington’s disease and epilepsy as well, with early results suggesting neuroprotective effects.19PubMed Central. Minor Cannabinoids: Biosynthesis, Molecular Pharmacology and Potential Therapeutic Uses
None of these minor cannabinoids are approved medications yet, and the jump from animal models to human therapies is famously unreliable. But the research illustrates why the question “can weed cause a seizure” resists a simple yes-or-no answer. The cannabis plant contains dozens of pharmacologically active compounds, each pulling on the brain’s electrical activity in different ways. What people call “weed” is really a cocktail whose recipe changes depending on the strain, the growing conditions, and the processing method. A product rich in CBD and minor cannabinoids might have a genuinely different seizure-risk profile than one dominated by high-potency THC, and the science is still catching up to that complexity.